
Daniel Rumack
Daniel Rumack leads global sales at Medclair and brings extensive knowledge of nitrous oxide (N₂O) decomposition, emissions reduction, and occupational exposure. Working closely with healthcare professionals and technical specialists internationally, he connects an understanding of decomposition technology with the practical challenges of delivering safer, more sustainable healthcare.
With a background in computer science from Stockholm University, Daniel has held CEO, Country Manager, and Nordic management positions across several technology sectors. His international leadership experience and technical understanding have been the foundations of his work on reducing the environmental impact of nitrous oxide, a subject closely aligned with Scotland’s healthcare sustainability ambitions.


